Qima Ventures
ActiveVenture Capital
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Qima Ventures.
Key people at Qima Ventures.
Key people at Qima Ventures.
QIMA is a global testing, inspection, and certification (TIC) company founded in 2005 that helps over 30,000 clients ensure product quality, safety, and compliance across consumer goods, food, life sciences, and pharmaceutical sectors. Its mission is to enable clients to make products consumers can trust by providing a comprehensive suite of services including onsite inspections, laboratory testing, supplier audits, and product certification. QIMA leverages advanced technology and AI through its proprietary SaaS platform, QIMAone, to streamline quality data collection and compliance management across global supply chains. The firm plays a critical role in enhancing transparency, sustainability, and regulatory conformity in complex international supply networks, impacting the startup and corporate ecosystems by setting high standards for product integrity and supply chain traceability[1][2][4].
Founded in Hong Kong in 2005 by Sebastien Breteau, QIMA began as a company focused on quality assurance services to help brands and retailers manage supplier compliance and product safety. Over time, it expanded its footprint to more than 70 offices and labs worldwide, evolving from traditional inspection services to a technology-driven platform integrating digital tools and AI. Key milestones include strategic acquisitions in life sciences and food sectors (2019-2025), and the launch of QIMAone in 2021, which marked its transition into SaaS solutions. The recent partnership with TA Associates, a global private equity firm, reflects QIMA’s ambition to accelerate growth and technological innovation[1][2].
QIMA rides the growing global trend toward supply chain transparency, sustainability, and digitalization. As regulatory demands and consumer expectations for product safety and ethical sourcing intensify, QIMA’s technology-enabled approach positions it to capitalize on the increasing need for integrated quality assurance solutions. The timing is critical as industries pivot to more responsible business practices, leveraging AI and digital platforms to manage complex, global supply chains efficiently. QIMA’s collaboration with traceability platforms like Retraced exemplifies its role in bridging physical inspections with digital verification, influencing broader ecosystem standards for compliance and sustainability[3][4].
Looking ahead, QIMA is poised to deepen its technological innovation, particularly in AI-driven quality assurance and expanded SaaS offerings, supported by TA Associates’ investment. Trends such as increased regulatory scrutiny, ESG compliance, and digital supply chain management will shape its growth trajectory. QIMA’s influence is likely to expand beyond traditional TIC services into integrated ecosystem solutions that combine data intelligence, sustainability, and compliance, reinforcing its leadership in global quality assurance. This evolution ties back to its founding mission of building trust in products worldwide through innovation and integrity[1][2][4].
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2023 | VarmX | $37.0M Series B | — | 2xN, Amadeus Capital Partners, Endeavor Venture Funds, EQT Life Sciences, RTW Investments |
| May 1, 2022 | Moon Surgical | $5.0M Series A | — | Cathay Health, Endeavor Venture Funds, EQT Life Sciences, New Enterprise Associates (NEA), RTW Investments, Soffinova Partners, Sonder Capital |
| Mar 1, 2021 | Visus Therapeutics | $36.0M Series A | — | Endeavor Venture Funds, EQT Life Sciences, RTW Investments |
| Jul 1, 2020 | VarmX | $36.0M Series B | — | Atlas Venture, Endeavor Venture Funds, EQT Life Sciences, INKEF Capital, RTW Investments |
